David
Moderator
- Joined
- Apr 24, 2003
- Messages
- 912
- Reason
- Other
- Diagnosis
- 00/0000
- Country
- CA
- State
- ON
- City
- Cobourg
Bobbi Greenberg of the ALS Society of Canada asked that we pass along the following information. Should any of you take the time to attend this online information session regarding the Ceftriaxone for ALS clinical trial please be sure to post your thoughts and commentary
A clinical study of Ceftriaxone in ALS is currently recruiting participants at 55 locations across Canada and the United States.
Merit Cudkowicz, MD, Principal Investigator, will be holding an informational web seminar for people interested in learning more about Ceftriaxone for ALS. This will be a time to learn about the scientific rationale behind the study, learn about study procedures, and ask questions.
Interested people can join the seminar on:
1. Please join this meeting by going online to:
2. Join the conference call by dialing:
Patients interested in participating in the study should contact:
----
If any of you attend please take a moment to comment on what you heard in this thread.
All the best,
David
A clinical study of Ceftriaxone in ALS is currently recruiting participants at 55 locations across Canada and the United States.
Merit Cudkowicz, MD, Principal Investigator, will be holding an informational web seminar for people interested in learning more about Ceftriaxone for ALS. This will be a time to learn about the scientific rationale behind the study, learn about study procedures, and ask questions.
Interested people can join the seminar on:
Tuesday, September 7th, 2010 @ 3:00 PM EST
1. Please join this meeting by going online to:
2. Join the conference call by dialing:
866-233-3841 (Toll Free) and entering the access code: 168092
Patients interested in participating in the study should contact:
Jane McKinley
Canadian Project Manager
Sunnybrook Health Sciences Centre
416-480-6860
Canadian Project Manager
Sunnybrook Health Sciences Centre
416-480-6860
----
If any of you attend please take a moment to comment on what you heard in this thread.
All the best,
David
Last edited: